Ljudski serumski albumin je najzastupljeniji protein u ljudskojkrvnoj plazmi. On se formira u jetri. Albumin sačinjava oko polovine krvnog serumskog proteina. On je rastvoran i monomeran. Albuminom se transportuju hormoni, masne kiseline, i druga jedinjenja, puferuje pH, i održava osmotski pritisak, i vrši niz drugih funkcija.[1][2]
Komatsu T; Nakagawa A; Curry S; et al. (2009). „The role of an amino acid triad at the entrance of the heme pocket in human serum albumin for O(2) and CO binding to iron protoporphyrin IX”. Org. Biomol. Chem. 7 (18): 3836—41. PMID19707690. doi:10.1039/b909794e.CS1 одржавање: Експлицитна употреба et al. (веза)
Silva AM, Hider RC (2009). „Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation”. Biochim. Biophys. Acta. 1794 (10): 1449—58. PMID19505594. doi:10.1016/j.bbapap.2009.06.003.
Otosu T, Nishimoto E, Yamashita S (2010). „Multiple conformational state of human serum albumin around single tryptophan residue at various pH revealed by time-resolved fluorescence spectroscopy”. J. Biochem. 147 (2): 191—200. PMID19884191. doi:10.1093/jb/mvp175.
Juárez J; Lápez SG; Cambán A; et al. (2009). „Influence of electrostatic interactions on the fibrillation process of human serum albumin”. J Phys Chem B. 113 (30): 10521—9. PMID19572666. doi:10.1021/jp902224d.CS1 одржавање: Експлицитна употреба et al. (веза)
Fu BL; Guo ZJ; Tian JW; et al. (2009). „[Advanced glycation end products induce expression of PAI-1 in cultured human proximal tubular epithelial cells through NADPH oxidase dependent pathway]”. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 25 (8): 674—7. PMID19664386.CS1 одржавање: Експлицитна употреба et al. (веза)
Curry S (2002). „Beyond expansion: structural studies on the transport roles of human serum albumin”. Vox Sang. 83 Suppl 1: 315—9. PMID12617161.
Guo S; Shi X; Yang F; et al. (2009). „Structural basis of transport of lysophospholipids by human serum albumin”. Biochem. J. 423 (1): 23—30. PMID19601929. doi:10.1042/BJ20090913.CS1 одржавање: Експлицитна употреба et al. (веза)
de Jong PE, Gansevoort RT (2009). „Focus on microalbuminuria to improve cardiac and renal protection”. Nephron Clin Pract. 111 (3): c204—10; discussion c211. PMID19212124. doi:10.1159/000201568.
Page TA; Kraut ND; Page PM; et al. (2009). „Dynamics of loop 1 of domain I in human serum albumin when dissolved in ionic liquids”. J Phys Chem B. 113 (38): 12825—30. PMID19711930. doi:10.1021/jp904475v.CS1 одржавање: Експлицитна употреба et al. (веза)
Roche M; Rondeau P; Singh NR; et al. (2008). „The antioxidant properties of serum albumin”. FEBS Lett. 582 (13): 1783—7. PMID18474236. doi:10.1016/j.febslet.2008.04.057.CS1 одржавање: Експлицитна употреба et al. (веза)
Cui FL; Yan YH; Zhang QZ; et al. (2010). „A study on the interaction between 5-Methyluridine and human serum albumin using fluorescence quenching method and molecular modeling”. J Mol Model. 16 (2): 255—62. PMID19588173. doi:10.1007/s00894-009-0548-4.CS1 одржавање: Експлицитна употреба et al. (веза)
Caridi G; Dagnino M; Simundic AM; et al. (2010). „Albumin Benkovac (c.1175 A > G; p.Glu392Gly): a novel genetic variant of human serum albumin”. Transl Res. 155 (3): 118—9. PMID20171595. doi:10.1016/j.trsl.2009.10.001.CS1 одржавање: Експлицитна употреба et al. (веза)
Deeb O; Rosales-Hernández MC; Gámez-Castro C; et al. (2010). „Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions”. Biopolymers. 93 (2): 161—70. PMID19785033. doi:10.1002/bip.21314.CS1 одржавање: Експлицитна употреба et al. (веза)
Karahan SC; Koramaz I; Altun G; et al. (2010). „Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study”. Eur Surg Res. 44 (1): 30—6. PMID19955769. doi:10.1159/000262324.CS1 одржавање: Експлицитна употреба et al. (веза)
Jin C; Lu L; Zhang RY; et al. (2009). „Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus”. Clin. Chim. Acta. 408 (1–2): 45—9. PMID19615354. doi:10.1016/j.cca.2009.07.003.CS1 одржавање: Експлицитна употреба et al. (веза)